Profile
William W.
Freimuth worked as a Clinical Director-Therapeutic Area at Pharmacia & Upjohn, Inc. and as a VP-Clinical Research, Immunology & Rheumatology at Human Genome Sciences, Inc. He holds a doctorate degree from Michigan State University and State University of New York at Buffalo, and an undergraduate degree from the University of Michigan.
Former positions of William W. Freimuth
Companies | Position | End |
---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 2011-08-21 |
Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
Training of William W. Freimuth
State University of New York at Buffalo | Doctorate Degree |
Michigan State University | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Pharmacia & Upjohn, Inc. | Health Technology |
- Stock Market
- Insiders
- William W. Freimuth